
 
 
 
 
 
 
 
 
   
 An isolated nucleic acid molecule selected from the group consisting of
 (a) an isolated nucleic acid molecule encoding a carotenoid ketolase enzyme having an amino acid sequence as set forth in any one of SEQ ID NOs:2,4, and 6; 
 (b) an isolated nucleic acid molecule encoding a carotenoid ketolase enzyme that is at least 240 amino acids in length and that has at least;
 (i) 75% sequence identity to SEQ ID NO: 2 or 6; or 
 (ii) 85% sequence identity to SEQ ID NO: 4; and   
 (c) an isolated nucleic acid molecule that is the complement of (a), or (b).   
 
     
 The isolated nucleic acid molecule of claim 1 which
 (a) encodes a sequence with at least:
 (i) 85% sequence identity to SEQ ID NO: 2 or 6; or 
 (ii) 90% sequence identity to SEQ ID NO: 4; or   
 (b) is the complement thereof.   
 
     
 The isolated nucleic acid molecule of claim 1 which
 (a) encodes a sequence with at least:
 (i) 90% sequence identity to SEQ ID NO; 2 or 6; or 
 (ii) 95% sequence identity to SEQ ID NO: 4; or   
 (b) is the complement thereof.   
 
     
 An isolated nucleic acid molecule according to any one of Claims 1 to 3 having a sequence selected from
 (a) the group consisting of SEQ ID NO:1, SEQ ID NO:3, and SEQ ID NO:5; 
 (b) a sequence that has at least:
 (i) 80% sequence identity to SEQ ID NO: 1 or 5; or 
 (ii) 90% sequence identity to SEQ ID NO: 3; and   
 (c) the complement of (a) or (b).   
 
     
 The isolated nucleic acid molecule of claim 1 comprising:
 (a) a sequence that encodes a carotenoid ketolase enzyme of at least 248 amino acids that has at least 75% identity based on the Smith-Waterman method of alignment when compared to a polypeptide having the sequence as set forth in SEQ ID NO:2; 
 (b) a sequence that encodes a carotenoid ketolase enzyme of at least 259 amino acids that has at least 85% identity based on the Smith-Waterman method of alignment when compared to a polypeptide having the sequence as set forth in SEQ ID NO:4; 
 (c) a sequence that encodes a carotenoid ketolase enzyme of at least 256 amino acids that has at least 75% identity based on the Smith-Waterman method of alignment when compared to a polypeptide having the sequence as set forth in SEQ ID NO:6; or 
 (d) the complement of any one of the nucleotide sequences of (a) to (c).   
 
     
 A polypeptide having carotenoid ketolase activity and having an amino acid sequence selected from
 (a) any one of SEQ ID NOs: 2, 4 and 6; 
 (b) a sequence that is at least 240 amino acids in length and that has at least;
 (i) 75% sequence identity to SEQ ID NO: 2 or 6; or 
 (ii) 85% sequence identity to SEQ ID NO: 4;   
 (c) a sequence encoded by a nucleotide sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 3, and SEQ ID NO: 5; 
 (d) a sequence encoded by a nucleotide sequence selected from a sequence that has at least;
 (i) 80% sequence identity to SEQ ID NO: 1 or 5; or 
 (ii) 90% sequence identity to SEQ ID NO: 3;   
 (e) a sequence of at least 248 amino acids that has at least 75% identity based on the Smith-Waterman method of alignment when compared to a polypeptide having the sequence as set forth in SEQ ID NO:2; 
 (f) a sequence of at least 259 amino acids that has at least 85% identity based on the Smith-Waterman method of alignment when compared to a polypeptide having the sequence as set forth in SEQ ID NO:4; and 
 (g) a sequence of at least 256 amino acids that has at least 75% identity based on the Smith-Waterman method of alignment when compared to a polypeptide having the sequence as set forth in SEQ ID NO:6.   
 
     
 A transformed host cell comprising the isolated nucleic acid molecule of any one of Claims 1 to 5. 
 
     
 The transformed host cell of Claim 7 wherein the host cell is selected from the group consisting of bacteria, yeast, filamentous fungi, algae, and green plants. 
 
     
 The transformed host cell of Claim 6 wherein the host cell is selected from the group consisting of  Aspergillus, Trichoderma, Saccharomyces, Pichia, Candida, Hansenula, Salmonella, Bacillus, Acinetobacter, Zymomonas, Agrobacterium, Erythrobacter, Chlorobium, Chromatium, Flavobacterium, Cytophaga, Rhodobacter, Rhodococcus, Streptomyces, Brevibacterium, Corynebacteria, Mycobacterium, Deinococcus, Escherichia, Erwinia, Pantoea, Pseudomonas, Sphingomonas, Methylomonas, Methylobacter, Methylococcus, Methylosinus, Methylomicrobium, Methylocystis, Alcaligenes, Synechocystis, Synechococcus, Anabaena, Thiobacillus, Methanobacterium, Klebsiella,  and  Myxococcus.   
 
     
 The transformed host cell of Claim 8 wherein the host cell is a C 1  metabolizing bacteria. 
 
     
 A method for the production of cyclic ketocarotenoid compounds comprising:
 (a) providing a host cell which produces cyclic carotenoids; 
 (b) transforming the host cell of (a) with an isolated nucleic acid molecule of any one of Claims 1 to 5 encoding a carotenoid ketolase enzyme as defined in Claim 6; and 
 (c) growing the transformed host cell of (b) under conditions whereby a cyclic ketocarotenoid is produced.   
 
     
 A method according to Claim 11 wherein the carotenoid ketolase gene encodes a polypeptide having the amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, and SEQ ID NO:6. 
 
     
 A method according to Claim 11 or 12 wherein the cyclic ketocarotenoid compounds are selected from a group consisting of canthaxanthin, astaxanthin, adonixanthin, adonirubin, echinenone, 3 hydroxyechinenone, 3'-hydroxyechinenone, 4-keto-gamma-carotene, 4 keto-rubixanthin, 4-keto-torulene, 3-hydroxy-4-keto-torulene, deoxyflexixanthin, myxobactone. 
 
     
 A method according to Claim 11 or 12 wherein the cyclic carotenoids are selected from the group consisting of -Carotene, γ-carotene, zeaxanthin, β-cryptozanthin, adonixanthin, 3-hydroyechinenone, 3'-hydroxyechinenone, rubixanthin, echinenone and torulene. 
 
     
 A method according to any one of Claims 11 to 14 wherein the transformed host is as defined in any one of claims 8 to 10. 
 
     
 A method for the increasing production of cyclic ketocarotenoid compounds comprising:
 (a) providing a host cell which produces cyclic carotenoids; 
 (b) transforming the host cell of (a) with a first nucleic acid molecule, said first nucleic acid mole selected from the nucleic acid molecule of any one of Claims 1 to 5, encoding a CrtW carotenoid ketolase enzyme as defined in claim 6; 
 (c) transforming the host cell of (a) with a second nucleic acid molecule encoding a CrtW carotenoid ketolase enzyme, said second nucleic acid molecule having less than 65% nucleic acid sequence identity when compared to said first nucleic acid molecule; and 
 (d) growing the transformed host cell comprising said first gene of (a) and said second gene of (b) under conditions whereby the production of cyclic ketocarotenoid is increased relative to a transformed host cell only expressing either said first gene or said second gene.   
 
     
 The method according to Claim 12 wherein the host cell is as defined in claim 8 or 9. 
 
   
 
 
 
 
 
 
 
 
